Eli Lilly, Novo Nordisk Battle It Out In Weight-Loss Pills Market

The weight-loss pills battle between Eli Lilly and Novo Nordisk could add to the projected $200 billion market for obesity drugs. The post Eli Lilly, Novo Nordisk Battle It Out In Weight-Loss Pills Market appeared first on Investor's Business Daily.